LicianPro

GNMSF stock

Genmab A/S (GNMSF) short interest & short volume · 0.1% of float short

Genmab A/S official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

GNMSF short interest fell 25.3% to 79K shares in the Oct 15, 2026 report (0.1% of float, 7.5 days to cover).

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
79K
prior 106K
% of float
0.1%
float 60.6M
Days to cover
7.5
avg vol 11K
Change vs prior report
-25.3%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

GNMSF short interest by FINRA report (last 6) · price is the close on the report date
Report dateShares short$ value shortChange% floatDays to coverPrice
Oct 15, 202679K$29.2M-25.3%0.1%7.5$367.00
Sep 30, 2026106K$37.8M-44.4%0.2%296.6$355.00
Sep 15, 2026191K$64.9M-3.4%0.3%47.4$338.98
Aug 31, 2026198K$67.0M-1.0%0.3%23.9$338.00
Aug 14, 2026200K$62.2M+0.5%0.3%528.0$310.63
Jul 31, 2026199K$57.6M+14.4%0.3%32.6$289.16

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

No FINRA daily short volume on file for GNMSF yet.

Short squeeze score (model)

Price since settlement: +38.8%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

GNMSF's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · GNMSF overview

Healthcare peers with similar quant ratings

GNMSF among 545 rated Healthcare stocks (Lician quant rating, Nov 13, 2026). How the rating works

GNMSF short interest FAQ

What is GNMSF's short interest?

Genmab A/S (GNMSF) had 79K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 0.1% of its 60.6M-share float.

How many days to cover does GNMSF have?

7.5 days: 79K shares short divided by an average daily volume of 11K for the Oct 15, 2026 period.

Is GNMSF short interest rising or falling?

GNMSF short interest fell (-25.3%) from 106K to 79K shares in the Oct 15, 2026 report.

Is GNMSF a short squeeze candidate?

Lician's squeeze watch scores GNMSF 39 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 0.2/40, days to cover 18.7/25, change in short interest vs prior report 0/15, price change since settlement date 20/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What is GNMSF's market cap?

Genmab A/S (GNMSF) market cap is $14.85B on the latest cached fundamentals snapshot.

Where is GNMSF short volume listed?

Cached FINRA short volume for Genmab A/S (GNMSF) is listed at https://lician.com/short-interest/gnmsf.

Not investment advice. Figures as filed or reported, not a live feed.